Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides

BACKGROUND: Therapeutic treatment options for chronic autoimmune disorders such as multiple sclerosis (MS) rely largely on the use of non-specific immunosuppressive drugs, which are not able to cure the disease. Presently, approaches to induce antigen-specific tolerance as a therapeutic approach; fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeil, Jennifer, Simonetti, Mario, Lauer, Uta, von Thülen, Bianca, Durek, Pawel, Poulsen, Christina, Pawlowska, Justyna, Kröger, Matthias, Krähmer, Ralf, Leenders, Frank, Hoffmann, Ute, Hamann, Alf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366199/
https://www.ncbi.nlm.nih.gov/pubmed/34408824
http://dx.doi.org/10.1177/20406223211037830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366199/
https://www.ncbi.nlm.nih.gov/pubmed/34408824
http://dx.doi.org/10.1177/20406223211037830

Ejemplares similares